Back to Journals » OncoTargets and Therapy » Volume 11

Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer

Total article views   Abstract views HTML views PDF downloads Totals
4,838 Dovepress* 4,387 285+ 288 4,672
PubMed Central* 0 166 79 166
Totals 4,387 451 367 4,838
*Since 19 September 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar